American Critical Medicine
Corporation (ACMC)

American Critical Medicine Corporation (ACMC) is a US-based Service-Disabled Veteran-Owned Small Business (SDVOSB) Company focused on addressing the United States Drug shortages. Working with public and private alliances, we strive to resolve the US drug shortages by leveraging our supply chain expertise. We are committed to providing secure and continuous access to critical drugs for the American public.

Executive Summary

ACMC is a pharmaceutical company dedicated to secure supply of critical medicines to the American healthcare system. By leveraging a global network of Contract Development and Manufacturing Organizations (CDMO) and partner, we efficiently develop, manufacture, and distribute essential medications while adhering to quality standard and regulatory compliance.

Strategic Vision

  • Biosecure Act Compliance: Aligning operations with the Biosecure Act to enhance supply chain security and reduce dependency on foreign entities posing national security risks
  • Global CDMO Utilization: Partnering with vetted, high-quality CDMOs across the globe to ensure a resilient and diversified supply chain.
  • Ensuring Drug Availability: Prioritizing the production of critical medicines to mitigate shortages and support national healthcare needs.

Environmental, Social, and Governance (ESG) Program

  • ACMC : Works with our suppliers with focus on sustainable sourcing while reducing caron footprint for a Sustainable Supply Chain.
  • Energy Efficiency & Carbon Footprint Reduction : Encourage contract manufacturers to use renewable energy and optimize energy-efficient production processes.
  • Waste Reduction & Green Packaging : Promote minimal and biodegradable packaging while ensuring regulatory compliance for pharmaceutical distribution.

  • Prioritize affordability and availability of critical medicines in the U.S. to reduce drug shortages for increased Access to Essential Medicines.

  • Regulatory Compliance & Transparency : Adhere to FDA, and other applicable regulatory requirements.
  • Data Security & Patient Privacy : Implement cybersecurity protocols to protect intellectual property, business data, and business operations.
  • Ethical Business Practices : Maintain anti-corruption and whistleblower policies to ensure integrity across partnerships and business dealings.
  • Board & Stakeholder Accountability : Establish an ESG advisory board to ensure continuous improvement and accountability in sustainability and governance.

  • Annual ESG Report : Publish an annual ESG performance report detailing sustainability achievements, challenges, and goals across supply chain.
  • Continuous Improvement : Regularly assess the program’s effectiveness and adjust policies to align with Industry best practices and Regulatory changes.

Commitment to ESG Principles

Our approach integrates Environmental, Social, and Governance (ESG) best practices, ensuring sustainable operations, ethical business conduct, and transparency. By focusing on regulatory compliance, ethical sourcing, and data security, we are establishing a responsible and forward-thinking pharmaceutical company dedicated to safeguarding public health.

We are a Disabled Veteran-Owned Business with Federal (SDVOSB) and State of California (DVBE) certification

Future Outlook

As we continue to expand our network and capabilities, we remain committed to driving innovation, enhancing supply chain resilience, and ensuring that critical medicines remain accessible to all Americans. Through strategic partnerships, regulatory diligence, and technological advancements, we aim to set global standards in pharmaceutical supply chain security and sustainability.